In a report released today, Chris Kotowski from Oppenheimer maintained a Hold rating on Alcentra Capital (ABDC). The company’s shares opened today at $7.54, close to its 52-week high of $7.86.
Kotowski wrote:
“ABDC shareholders endured three gruesome years from 2015 to year-end 2017 as NAV dropped some 25% from nearly $15 to $11.09 and the dividend was cut twice from $0.34 per quarter briefly to $0.25 and then to $0.18. The market has not yet forgotten, and the shares are down another 11% since year-end 2017, but that of course is not in the company’s control. What they can control seems to be stabilizing. NAV ended 2018 at $11.13, up a tick from both the prior quarter and the prior year. Also encouraging is that they covered the dividend out of operating net investment income (NII).”
According to TipRanks.com, Kotowski is a 5-star analyst with an average return of 10.7% and a 63.4% success rate. Kotowski covers the Financial sector, focusing on stocks such as Apollo Global Management LLC, Fidus Investment Corporation, and Oaktree Capital Group Llc.
The the analyst consensus on Alcentra Capital is currently a Hold rating.
See today’s analyst top recommended stocks >>
Based on Alcentra Capital’s latest earnings release for the quarter ending September 30, the company reported a quarterly net profit of $3.08 million. In comparison, last year the company had a GAAP net loss of $13.37 million.
Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ABDC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alcentra Capital Corp. is a non-diversified closed-end management investment company, which engages in the provision of debt and equity financing solutions to lower middle and middle-market companies. It targets industries operating in the field of healthcare and pharmaceutical services; defense, aerospace, homeland security and government services; and business and outsourced services. The company was founded on June 6, 2013 and is headquartered in New York, NY.
